Pompano Beach, Florida, July 18, 2011 - PetMed Express, Inc. (NASDAQ: PETS) today announced its financial results for the quarter ended June 30, 2011. Net sales for the quarter ended June 30, 2011 were $73.6 million, compared to $74.4 million for the quarter ended June 30, 2010, a decrease of 1.1%. Net income was $4.8 million, or $0.22 diluted per share, for the quarter ended June 30, 2011, compared to net income of $7.2 million, or $0.32 diluted per share, for the quarter ended June 30, 2010, a 30% decrease to EPS. New order sales increased by 1.3%, from $16.7 million to $17.0 million for the quarters ended June 30, 2010 and 2011, respectively. The Company acquired approximately 226,000 new customers for the quarter ended June 30, 2011, compared to 220,000 new customers for the quarter ended June 30, 2010.

Menderes Akdag, CEO and President, commented: “Although our sales were slightly down due to our more aggressive flea & tick product pricing, we had a slight increase in orders, which was a positive. Additionally, our online sales increased by 3.4% to $54.1 million for the quarter, compared to $52.3 million for the quarter the prior year, with approximately 73% of our orders being generated from our website during the quarter compared to 70% for the quarter the prior year. During the quarter we bought back approximately 1.1 million shares of our common stock for $13.6 million, an average price of $12.67 per share.”

This morning at 8:30 A.M. Eastern Time, Mr. Akdag will host a conference call to review the quarter’s financial results. To access the call, which is open to the public, please dial (888) 455-1758 (toll free) or (210) 234-0009. Callers will be required to supply PETMEDS as the passcode. For those unable to participate in the live event, the call will be available for replay from 10:00 A.M. on July 18, 2011 until August 1, 2011 at 11:59 P.M. To access the replay, call (800) 896-3843 (toll free) or (203) 369-3847, and enter passcode 5500.

Founded in 1996, PetMed Express is America’s Largest Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs and cats at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet through its website at

This press release may contain “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company’s ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such “forward-looking” statements are set forth in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2011. The Company’s future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K.

For investment relations contact PetMed Express, Inc., Bruce S. Rosenbloom, CFO, 954-979-5995.